AIDA Stock Chart & Stats
$0.01
<$0.01(50.50%)
At close: 4:00 PM EST
$0.01
<$0.01(50.50%)
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume500.00
Average Volume (3M)0.00
Market Cap
$8.13K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)<0.1
Beta0.68
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding27,000,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
AIDA FAQ
What was AiDa Pharmaceuticals Inc’s price range in the past 12 months?
AiDa Pharmaceuticals Inc lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is AiDa Pharmaceuticals Inc’s market cap?
AiDa Pharmaceuticals Inc’s market cap is $8.13K.
When is AiDa Pharmaceuticals Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were AiDa Pharmaceuticals Inc’s earnings last quarter?
Currently, no data Available
Is AiDa Pharmaceuticals Inc overvalued?
According to Wall Street analysts AiDa Pharmaceuticals Inc’s price is currently Overvalued.
Does AiDa Pharmaceuticals Inc pay dividends?
AiDa Pharmaceuticals Inc does not currently pay dividends.
What is AiDa Pharmaceuticals Inc’s EPS estimate?
AiDa Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AiDa Pharmaceuticals Inc have?
AiDa Pharmaceuticals Inc has 27,000,000 shares outstanding.
What happened to AiDa Pharmaceuticals Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of AiDa Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in AIDA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
AiDa Pharmaceuticals Inc
Aida Pharmaceuticals, Inc., together with its affiliates, operates extensively throughout mainland China, specializing in the entire spectrum of pharmaceutical and genetic product development. This encompasses formulation, clinical trials, regulatory registration, manufacturing, sales, and marketing. The company's diverse product range includes antibiotics, cardiovascular medicines, and anti-cancer drugs. These are available in various forms, such as injectable powders, intravenous liquids, capsules, tablets, and ointments. Notable products feature Etimicin Sulfate, provided as an injectable powder, and rh-Apo2l, a biopharmaceutical therapy targeting cancers. Established in 1999, Aida Pharmaceuticals, Inc. is headquartered in Hangzhou, China.
Technical Analysis
RedHill Biopharma
―
cbdMD
―
PainReform
―
Universe Pharmaceuticals
―
Shuttle Pharmaceuticals Holdings, Inc.
―